Results 151 to 160 of about 30,645 (194)
Development and internal validation of a CatBoost-SHAP-guided nomogram for significant liver fibrosis in children with chronic hepatitis B. [PDF]
Zhang Y +11 more
europepmc +1 more source
KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA). [PDF]
Choi WM +19 more
europepmc +1 more source
HBeAg Seroconversion as an Important End Point in the Treatment of Chronic Hepatitis B [PDF]
During the natural history of chronic hepatitis B virus (HBV) infection, the loss of serum hepatitis B e antigen (HBeAg) and the development of anti-HBe antibodies (HBeAg seroconversion) mark a transition from the immune-active phase of disease to the inactive carrier state.
Yun-Fan Liaw
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hepatology International, 2014
It remains unclear whether chronic hepatitis B patients who undergo interferon (IFN)-induced hepatitis B e antigen (HBeAg) seroconversion have a higher risk of hepatitis B virus (HBV) reactivation and HBeAg seroreversion than those with spontaneous HBeAg seroconversion.A total of 80 and 251 non-cirrhotic patients with interferon-induced and spontaneous
Jing-Houng Wang +2 more
exaly +3 more sources
It remains unclear whether chronic hepatitis B patients who undergo interferon (IFN)-induced hepatitis B e antigen (HBeAg) seroconversion have a higher risk of hepatitis B virus (HBV) reactivation and HBeAg seroreversion than those with spontaneous HBeAg seroconversion.A total of 80 and 251 non-cirrhotic patients with interferon-induced and spontaneous
Jing-Houng Wang +2 more
exaly +3 more sources
Liver International, 2010
HBeAg seroconversion, in association with undetectable levels of hepatitis B virus DNA as determined by polymerase chain reaction, is an important goal in the treatment of patients with HBeAg-positive chronic hepatitis B (CHB). Achievement of sustained HBeAg seroconversion at an early age (
George Lau
exaly +3 more sources
HBeAg seroconversion, in association with undetectable levels of hepatitis B virus DNA as determined by polymerase chain reaction, is an important goal in the treatment of patients with HBeAg-positive chronic hepatitis B (CHB). Achievement of sustained HBeAg seroconversion at an early age (
George Lau
exaly +3 more sources
Liver International, 2011
Abstract Background and aims: This cohort study investigated the long‐term effect of maternal hepatitis B virus (HBV) sero‐status on the spontaneous HBeAg seroconversion in offspring with chronic HBV infection. Methods: A total of 185 HBeAg‐positive chronic HBV‐infected children, with maternal HBV seromarkers checked, were ...
Jia-Feng Wu, Wan-Hsin Wen, Yen-Hsuan Ni
exaly +3 more sources
Abstract Background and aims: This cohort study investigated the long‐term effect of maternal hepatitis B virus (HBV) sero‐status on the spontaneous HBeAg seroconversion in offspring with chronic HBV infection. Methods: A total of 185 HBeAg‐positive chronic HBV‐infected children, with maternal HBV seromarkers checked, were ...
Jia-Feng Wu, Wan-Hsin Wen, Yen-Hsuan Ni
exaly +3 more sources
Lamivudine-induced HBeAg seroconversion may not be durable in Korean patients with hepatitis B virus (HBV) infection. It is unknown whether virological response during lamivudine treatment affects the post-treatment outcome.
Sung-Won Cho, K B Hahm
exaly +2 more sources
Relative Predictive Factors for Hepatocellular Carcinoma After HBeAg Seroconversion in HBV Infection
To determine the predictive factors for hepatocellular carcinoma (HCC) development in patients after spontaneous or therapeutic HBeAg seroconversion.In 48 patients who seroconverted to anti-HBe positive during follow-up, the background factors for HCC development were analyzed.HCC was developed in six patients during follow-up (average follow-up after ...
Kazumoto Murata +2 more
exaly +3 more sources

